Central CB2 receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential
Main Authors: | Ruth M Concannon, Eilís Dowd |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=9;spage=1409;epage=1410;aulast=Concannon |
Similar Items
-
CB2 and GPR55 receptors as therapeutic targets for systemic immune dysregulation
by: Juan Zhou, et al.
Published: (2016-08-01) -
Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
by: M. Galán-Ganga, et al.
Published: (2021-05-01) -
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.
by: Vanessa Deveaux, et al.
Published: (2009-01-01) -
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018-06-01) -
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells
by: Haddad M
Published: (2021-08-01)